These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 8433517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?
    Desch K, Motto D.
    J Am Soc Nephrol; 2007 Sep; 18(9):2457-60. PubMed ID: 17687074
    [Abstract] [Full Text] [Related]

  • 3. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
    Sánchez Avalos JC.
    Medicina (B Aires); 2000 Sep; 60(1):46-58. PubMed ID: 10835700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN.
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [Abstract] [Full Text] [Related]

  • 6. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG, Kirsztajn GM.
    J Bras Nefrol; 2010 Dec; 32(3):303-15. PubMed ID: 21103695
    [Abstract] [Full Text] [Related]

  • 7. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 8. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L.
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P, Remuzzi G.
    J Nephrol; 1998 Apr; 11(6):300-10. PubMed ID: 10048496
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ, Moake JL.
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Shah NT, Rand JH.
    Mt Sinai J Med; 2003 Oct; 70(5):344-51. PubMed ID: 14631521
    [Abstract] [Full Text] [Related]

  • 14. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
    Fakhouri F, Frémeaux-Bacchi V.
    Nat Clin Pract Nephrol; 2007 Dec; 3(12):679-87. PubMed ID: 18033227
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 16. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H, Saitoh M, Tamaki S, Masuya M, Morita K, Tabata M, Tanigawa M, Kageyama S, Tsuzi K, Ohta C.
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [Abstract] [Full Text] [Related]

  • 17. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M, Fehr J, Gmür J, Keusch G, Frick P, Oelz O.
    Schweiz Med Wochenschr; 1986 Nov 29; 116(48):1666-74. PubMed ID: 3798063
    [Abstract] [Full Text] [Related]

  • 18. [Pathophysiology of thrombotic microangiopathies: current understanding].
    Coppo P, Veyradier A, Durey MA, Fremeaux-Bacchi V, Scrobohaci ML, Amesland F, Bussel A.
    Ann Med Interne (Paris); 2002 May 29; 153(3):153-66. PubMed ID: 12218898
    [Abstract] [Full Text] [Related]

  • 19. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
    Mauro M, Kim J, Costello C, Laurence J.
    Am J Hematol; 2001 Jan 29; 66(1):12-22. PubMed ID: 11426486
    [Abstract] [Full Text] [Related]

  • 20. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Elliott MA, Nichols WL.
    Mayo Clin Proc; 2001 Nov 29; 76(11):1154-62. PubMed ID: 11702904
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.